Clay B. Siegall Ph.D.

Clay B. Siegall Ph.D.

President, Chief Executive Officer and Chairman of the Board at Seattle Genetics, Inc.

Are you Clay B. Siegall Ph.D.? Claim your profile
 
  • IDENTIFY corporate executives in Clay B. Siegall Ph.D.'s network and community.
  • FOLLOW changes in Clay B. Siegall Ph.D.'s employment and money-in-motion.
  • CONNECT with Clay B. Siegall Ph.D. through your network of contacts.

Clay B. Siegall Ph.D.'s Executive Bio


Current
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.
Board Member, Alder Biopharmaceuticals
Board Member, Mirna Therapeutics
Past
To view Clay B. Siegall Ph.D.'s complete executive bio,
Education
Age
55
 

Clay B. Siegall Ph.D.'s Annual Salary, Stock and Options


Salary and Bonus
Stock Awards
Option Awards
$1,990,908
$2,505,600
$3,178,841
 

Clay B. Siegall Ph.D.'s Insider Transactions


Last 3 years
Option Exercised
Stock Sold
New Equity Grants
$17,512,890
$27,277,526
$18,332,164
Next 3 years
Upcoming Wealth
Develop prospecting strategies based on upcoming wealth events.
 

Clay B. Siegall Ph.D.'s Net Worth


Equity Holdings
To view Clay B. Siegall Ph.D.'s total equity holdings,
 

Clay B. Siegall Ph.D.'s Recent Events


Equity vested $70,606 (Seattle Genetics, Inc.)
03/26/2017
Stock sold $983,186 (Seattle Genetics, Inc.)
03/06/2017
Options exercised $834,705 (Seattle Genetics, Inc.)
03/06/2017
New bonus target (Seattle Genetics, Inc.)
01/26/2017
 
 
To see 32 additional events for Clay B. Siegall Ph.D.,
 

Clay B. Siegall Ph.D.'s Biography


Dr. Siegall has served as a member of our Board of Directors since November 2005. In 1998, Dr. Siegall co-founded Seattle Genetics, Inc., a biotechnology company, and currently serves as its President, Chief Executive Officer and Chairman of the Board of Directors. From 1991 to 1997, Dr. Siegall was with the Bristol-Myers Squibb Pharmaceutical Research Institute and the National Cancer Institute, National Institutes of Health from 1988 to 1991. In addition to Seattle Genetics, Dr. Siegall currently serves on the board of directors of Ultragenyx Pharmaceutical Inc. and Mirna Therapeutics, Inc. Dr. Siegall holds a Ph.D. in Genetics from George ...

(Read More)

Source: Alder Biopharmaceuticals on 04/06/2016

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Clay B. Siegall Ph.D.. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Clay B. Siegall Ph.D.'s network and community.
  • FOLLOW changes in Clay B. Siegall Ph.D.'s employment and money-in-motion.
  • CONNECT with Clay B. Siegall Ph.D. through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Clay B. Siegall Ph.D.

Top 10 Executive Lists


View top 10 executives by events such as Salary, Stock Sale, Resignations, or Appointments

Clay B. Siegall Ph.D.'s Connections (92)


Chief Operating Officer, Seattle Genetics, Inc.
Chief Technical Officer, Seattle Genetics, Inc.
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.
Chief Financial Officer, Seattle Genetics, Inc.
Dir., President and Chief Executive Officer, Relypsa, Inc.
Chairman of the Board, Amarin Corporation plc
Dir., President and Chief Executive Officer, Syros Pharmaceuticals